Duchenne News Tags: Precision Biosciences

August 24, 2026
Precision BioSciences has dosed the first patient at Arkansas Children’s Hospital, a PPMD Certified Duchenne Care Center and designated MDA Care Center, in the Phase 1/2 Function-DMD clinical trial evaluating...
July 29, 2025
On July 16, 2025, Precision BioSciences, Inc. announced updated additional preclinical data further validating the scientific rationale supporting the rapid development of PBGENE-DMD, the Company’s first-in-class in vivo gene editing approach for...